Cargando…
Dynamic circulating tumor DNA quantificaton for the individualization of non-small-cell lung cancer patients treatment
BACKGROUND: Liquid biopsy has evolved from being a promising line to becoming a validated approach for biomarker testing. However, its utility for individualization of therapy has been scarcely reported. In this study, we show how monitoring levels of EGFR mutation in plasma can be useful for the in...
Autores principales: | Provencio, Mariano, Torrente, María, Calvo, Virgina, Gutiérrez, Lourdes, Pérez-Callejo, David, Pérez-Barrios, Clara, Barquín, Miguel, Royuela, Ana, Rodriguez-Alfonso, Begoña, Sotelo, Miguel, Cruz-Bermúdez, Juan Luis, Mendez, Miriam, Cruz-Bermúdez, Alberto, Romero, Atocha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601139/ https://www.ncbi.nlm.nih.gov/pubmed/28947971 http://dx.doi.org/10.18632/oncotarget.20016 |
Ejemplares similares
-
Prognostic value of quantitative ctDNA levels in non small cell lung cancer patients
por: Provencio, Mariano, et al.
Publicado: (2017) -
Concordance between circulating tumor cells and clinical status during follow-up in anaplastic lymphoma kinase (ALK) non-small-cell lung cancer patients
por: Provencio, Mariano, et al.
Publicado: (2017) -
ctDNA analysis reveals different molecular patterns upon disease progression in patients treated with osimertinib
por: Romero, Atocha, et al.
Publicado: (2020) -
Long-term follow up of Hodgkin lymphoma
por: Perez-Callejo, David, et al.
Publicado: (2018) -
PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy
por: Cruz-Bermúdez, Alberto, et al.
Publicado: (2017)